Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10576
PUT
TTM Technologies
TTMI
$14.7B
| $181K | ﹤0.01% |
7,300
-22,700
| -76% | -$514K |
|
|
BRDG
10577
CALL
DELISTED
Bridge Investment Group
BRDG
| $181K | ﹤0.01% |
21,500
+3,900
| +22% | +$38.3K |
|
10578
PUT
1-800-Flowers.com
FLWS
$262M
| $181K | ﹤0.01% |
22,100
+14,400
| +187% | +$115K |
|
10579
CALL
Stem
STEM
$61M
| $181K | ﹤0.01% |
14,970
+10,515
| +236% | +$90.5K |
|
|
AMIX
10580
Autonomix Medical
AMIX
$3.72M
| $180K | ﹤0.01% |
+2,280
| New | +$403K |
|
10581
PUT
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $180K | ﹤0.01% |
4,100
+3,900
| +1,950% | +$182K |
|
10582
PUT
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.73M
| $180K | ﹤0.01% |
2,350
+2,100
| +840% | +$128K |
|
10583
Brilliant Earth
BRLT
$22.5M
| $180K | ﹤0.01% |
85,508
+71,795
| +524% | +$132K |
|
|
CTO
10584
PUT
CTO Realty Growth
CTO
$825M
| $179K | ﹤0.01% |
9,100
-9,900
| -52% | -$195K |
|
10585
CALL
Banco Santander
SAN
$210B
| $179K | ﹤0.01% |
39,300
+9,400
| +31% | +$45.2K |
|
10586
CALL
Driven Brands
DRVN
$2.13B
| $179K | ﹤0.01% |
11,100
-17,300
| -61% | -$271K |
|
10587
PTC
PTC
$16.2B
| $179K | ﹤0.01% |
+974
| New | +$185K |
|
10588
PUT
iShares MSCI USA Quality Factor ETF
QUAL
$48.1B
| $178K | ﹤0.01% |
1,000
+200
| +25% | +$36.3K |
|
10589
Spero Therapeutics
SPRO
$71.6M
| $178K | ﹤0.01% |
172,872
+91,447
| +112% | +$109K |
|
|
OZEM
10590
CALL
Roundhill GLP-1 & Weight Loss ETF
OZEM
$63.7M
| $178K | ﹤0.01% |
7,300
-24,900
| -77% | -$670K |
|
10591
CALL
Tootsie Roll Industries
TR
$3.08B
| $178K | ﹤0.01% |
5,835
-6,047
| -51% | -$179K |
|
10592
CALL
Lindsay Corp
LNN
$1.17B
| $177K | ﹤0.01% |
1,500
-7,300
| -83% | -$907K |
|
|
KRON
10593
DELISTED
Kronos Bio
KRON
| $177K | ﹤0.01% |
186,711
+99,510
| +114% | +$93.9K |
|
10594
PUT
First Trust Natural Gas ETF
FCG
$648M
| $177K | ﹤0.01% |
7,200
-13,500
| -65% | -$333K |
|
10595
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
| $177K | ﹤0.01% |
3,500
+300
| +9% | +$17.8K |
|
10596
PUT
Tenable Holdings
TENB
$4.22B
| $177K | ﹤0.01% |
4,500
-80,300
| -95% | -$3.33M |
|
10597
PUT
Moog Inc Class A
MOG.A
$14B
| $177K | ﹤0.01% |
900
+200
| +29% | +$41.1K |
|
10598
PUT
Brown-Forman Class A
BF.A
$13.3B
| $177K | ﹤0.01% |
4,700
+3,500
| +292% | +$151K |
|
10599
Blue Ridge Bankshares
BRBS
$331M
| $177K | ﹤0.01% |
54,964
-50,015
| -48% | -$158K |
|
|
EFC
10600
CALL
Ellington Financial
EFC
$1.76B
| $177K | ﹤0.01% |
14,600
-5,300
| -27% | -$65.5K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.